Flower Orthopedics develops the sterile FlowerCube system for eliminating expensive set processing, enabling surgical facilities to complete back-to-back cases, enhance efficiency and maximize resources, according to a news release.
In addition to its fixation portfolio, Flower also drew interest from Conventus with its extension into the wound care market for orthopedic and podiatric surgeons.
“Flower is an excellent strategic fit with Conventus,” Conventus CEO Rick Epstein said in the release. “With ongoing concerns over viral and infection risks associated with heavy reusable orthopedic implant trays, Flower’s Ready-for-Surgery platform reduces exposure to bioburden while enhancing OR efficiencies.
We will continue to develop and acquire innovative products and companies that improve procedures, patient outcomes and safety for orthopedic and foot & ankle surgeons.”
Conventus develops the platform nitinol Cage technology for treating proximal humerus and distal radius fractures. It is currently developing a lower extremity Cage implant system along with a new distal fibula intramedullary nailing system.